Screener
Prime Medicine PRME Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $666.48M.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's market capitalization?
- Prime Medicine (PRME) reported market capitalization of $666.48M in Q2 2026.
- How has Prime Medicine's market capitalization changed year-over-year?
- Prime Medicine's market capitalization increased by 135.0% year-over-year, from $283.6M to $666.48M.
- What is the long-term trend for Prime Medicine's market capitalization?
- Over 3 years (2022 to 2025), Prime Medicine's market capitalization has grown at a -23.1% compound annual growth rate (CAGR), from $1.38B to $626.37M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Prime Medicine's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude